Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fibroblast Growth Factor 1"" wg kryterium: Temat


Tytuł:
Significant Enhancement of Fibroblast Migration, Invasion, and Proliferation by Exosomes Loaded with Human Fibroblast Growth Factor 1.
Autorzy:
Hade MD; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida 32306, United States.
Suire CN; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida 32306, United States.
Suo Z; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida 32306, United States.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Jan 17; Vol. 16 (2), pp. 1969-1984. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/metabolism
Fibroblast Growth Factor 1*/pharmacology
Exosomes*/metabolism
Animals ; Humans ; Wound Healing ; Cell Proliferation ; Fibroblasts ; Mammals
Czasopismo naukowe
Tytuł:
ERK1/2-dependent activity of SOX9 is required for sublytic C5b-9-induced expression of FGF1, PDGFα, and TGF-β1 in rat Thy-1 nephritis.
Autorzy:
Wu Z; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Zhang Z; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Zhou S; School of Pediatrics, Nanjing Medical University, Nanjing, China.
Xie M; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Liu L; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Luo C; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Zheng F; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Qiu W; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China; Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China; National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China.
Wang Y; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China; Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China; National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China.
Zhang J; Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China; Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China; National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Jan 25; Vol. 127, pp. 111372. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/genetics
Fibroblast Growth Factor 1*/metabolism
Nephritis*/metabolism
Rats ; Animals ; Phosphorylation ; Rats, Sprague-Dawley ; Complement Membrane Attack Complex/metabolism ; Transforming Growth Factor beta1/genetics ; Transforming Growth Factor beta1/metabolism ; MAP Kinase Signaling System ; Serine/metabolism
Czasopismo naukowe
Tytuł:
The optimized priming effect of FGF-1 and FGF-2 enhances preadipocyte lineage commitment in human adipose-derived mesenchymal stem cells.
Autorzy:
Tarapongpun T; Division of Head Neck and Breast Surgery, Faculty of Medicine Siriraj Hospital, Department of Surgery, Mahidol University, Bangkok, Thailand.; Department of Stem Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Onlamoon N; Department of Research, Faculty of Medicine Siriraj Hospital, Siriraj Research Group in Immunobiology and Therapeutic Sciences, Mahidol University, Bangkok, Thailand.
Tabu K; Department of Stem Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Chuthapisith S; Division of Head Neck and Breast Surgery, Faculty of Medicine Siriraj Hospital, Department of Surgery, Mahidol University, Bangkok, Thailand.
Taga T; Department of Stem Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło:
Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2024 Mar; Vol. 29 (3), pp. 231-253. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/pharmacology
Mesenchymal Stem Cells*
Humans ; Adipogenesis ; Cell Differentiation ; Cells, Cultured ; Epidermal Growth Factor/pharmacology ; Fibroblast Growth Factor 2/pharmacology ; PPAR gamma/metabolism
Czasopismo naukowe
Tytuł:
Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defects.
Autorzy:
Zhang YL; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Tang TT; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Ni WJ; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Li ZT; Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, China.
Jiang LY; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Wang Y; Department of Nephrology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
Zhou X; Shanghai OE Biotech Co., Ltd., Shanghai, China.
Cao JY; Institute of Nephrology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Nanjing, Jinagsu, China.
Yin Q; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Jiang W; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Zhao YJ; Department of Pediatric Nephrology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Gan WH; Department of Pediatric Nephrology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Zhang AQ; Department of Pediatric Nephrology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Li ZL; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Wen Y; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Lv LL; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Liu BC; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Wang B; Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło:
International journal of biological sciences [Int J Biol Sci] 2024 Feb 12; Vol. 20 (5), pp. 1669-1687. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/genetics
Acute Kidney Injury*/chemically induced
Humans ; Mice ; Animals ; Cyclin-Dependent Kinases/genetics ; Kidney ; Genomic Instability
Czasopismo naukowe
Tytuł:
Intracellular FGF1 protects cells from apoptosis through direct interaction with p53.
Autorzy:
Lampart A; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Krowarsch D; Department of Protein Biotechnology, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Biadun M; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.; Department of Protein Biotechnology, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Sorensen V; Advanced Light Microscopy Core Facility, Dept. Core Facilities, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Oslo, Norway.
Szymczyk J; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Sluzalska K; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Wiedlocha A; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Oslo, Norway.; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.
Otlewski J; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.
Zakrzewska M; Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland. .
Pokaż więcej
Źródło:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Oct 02; Vol. 80 (10), pp. 311. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/genetics
Fibroblast Growth Factor 1*/metabolism
Fibroblast Growth Factor 1*/pharmacology
Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Receptor Protein-Tyrosine Kinases/metabolism ; Signal Transduction ; Apoptosis
Czasopismo naukowe
Tytuł:
FGF1 promotes the differentiation of goat intramuscular and subcutaneous preadipocytes.
Autorzy:
Cui S; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Li X; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Li R; Reproductive and Endocrine Laboratory, Chengdu Woman-Child Central Hospital, Chengdu, China.
Zhang H; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Wang Y; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Li Y; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Zhu J; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.
Li Z; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Lin Y; Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China.; Key Laboratory of Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Exploitation, Southwest Minzu University, Chengdu, China.; College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, China.
Pokaż więcej
Źródło:
Animal biotechnology [Anim Biotechnol] 2023 Nov; Vol. 34 (4), pp. 1196-1208. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/genetics
Fibroblast Growth Factor 1*/metabolism
Goats*/physiology
Animals ; PPAR gamma/metabolism ; Cell Differentiation/physiology ; Adipocytes/physiology
Czasopismo naukowe
Tytuł:
FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Autorzy:
Castillo-Castrejon M; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Sankofi BM; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Murguia SJ; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Udeme AA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Cen HH; Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Xia YH; Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Thomas NS; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Berry WL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Jones KL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.
Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital and McGill University, Montreal, QC, Canada.
Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, R3E 0V9, Canada.
Borchers CH; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, H4A 3J1, Canada.; Department of Pathology, McGill University, Montreal, QC, H3A 2B4, Canada.
Johnson JD; Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Wellberg EA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA. .
Pokaż więcej
Źródło:
Breast cancer research : BCR [Breast Cancer Res] 2023 Aug 22; Vol. 25 (1), pp. 99. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Fibroblast Growth Factor 1*/metabolism
Receptors, Estrogen*/genetics
Breast Neoplasms*/metabolism
Animals ; Female ; Mice ; Estradiol ; Estrogens ; Ligands ; Obesity/complications ; Proteomics ; Weight Gain
Czasopismo naukowe
Tytuł:
Identification of key miRNAs in unilateral mastication-induced disruption of cartilage homeostasis.
Autorzy:
Wu M; Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China.
Wang X; College of Life Sciences, Zhejiang University, Hangzhou, China.
Shuai J; Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China.
Deng L; School of Stomatology, Zhejiang Chinese Medical University, Hangzhou, China.
Lu H; School of Stomatology, Zhejiang Chinese Medical University, Hangzhou, China.
Zhou Y; Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China.
Wu M; College of Life Sciences, Zhejiang University, Hangzhou, China.
Pokaż więcej
Źródło:
Oral diseases [Oral Dis] 2024 Mar; Vol. 30 (2), pp. 551-561. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Rats ; Animals ; Core Binding Factor Alpha 1 Subunit ; Matrix Metalloproteinase 13/genetics ; Matrix Metalloproteinase 1 ; Fibroblast Growth Factor 1 ; Mastication ; Rats, Sprague-Dawley ; Cartilage/metabolism ; Homeostasis
Czasopismo naukowe
Tytuł:
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation.
Autorzy:
Tejedor S; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden.
Wågberg M; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Correia C; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Åvall K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Hölttä M; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Hultin L; Imaging and Data Analytics, Clinical and Pharmacological Safety Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Lerche M; Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Davies N; Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Bergenhem N; Alliance Management, Business Development and Licensing, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA 02451, USA.
Snijder A; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Marlow T; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Dönnes P; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden.; SciCross AB, 541 35 Skövde, Sweden.
Fritsche-Danielson R; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Synnergren J; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
Jennbacken K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Hansson K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*
Diabetic Foot*
Humans ; Mice ; Animals ; Vascular Endothelial Growth Factor A/metabolism ; Fibroblast Growth Factor 1 ; Neovascularization, Physiologic/physiology ; Wound Healing/physiology ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist.
Autorzy:
Chang CC; Department of Dermatology, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.; Department of Biochemistry and Molecular Medicine, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.
Takada YK; Department of Dermatology, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.
Cheng CW; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Maekawa Y; Department of Medical Technology, Faculty of Health Science, Morinomiya University of Medical Sciences, Osaka 536-0025, Japan.
Mori S; Department of Medical Technology, Faculty of Health Science, Morinomiya University of Medical Sciences, Osaka 536-0025, Japan.; Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
Takada Y; Department of Dermatology, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.; Department of Biochemistry and Molecular Medicine, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 07; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Integrin alphaVbeta3*/metabolism
Mitogens*
Ligands ; Fibroblast Growth Factor 1 ; Fibroblast Growth Factor 2 ; DNA
Czasopismo naukowe
Tytuł:
FGF1 reduces cartilage injury in osteoarthritis via regulating AMPK/Nrf2 pathway.
Autorzy:
Li YX; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Shu J; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Kou NN; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Chen HB; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Guo LM; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Yuan Y; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
He SX; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Zhao G; Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China. .
Pokaż więcej
Źródło:
Journal of molecular histology [J Mol Histol] 2023 Oct; Vol. 54 (5), pp. 427-438. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoarthritis*/metabolism
Cartilage, Articular*/metabolism
Humans ; Fibroblast Growth Factor 1/metabolism ; Fibroblast Growth Factor 1/pharmacology ; NF-E2-Related Factor 2/metabolism ; AMP-Activated Protein Kinases/metabolism ; Chondrocytes/metabolism ; Cartilage/metabolism
Czasopismo naukowe
Tytuł:
Beneficial Effects of Oleosomes Fused with Human Fibroblast Growth Factor 1 on Wound Healing via the Promotion of Angiogenesis.
Autorzy:
Guo Y; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Chu G; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Cai W; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Li Y; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Lan X; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Li J; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Du L; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Yang J; Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, No. 2888, Xincheng Street, Changchun 130118, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 29; Vol. 23 (21). Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 1*/pharmacology
Fibroblast Growth Factor 1*/therapeutic use
Lipid Droplets*/metabolism
Wound Healing*/drug effects
Wound Healing*/physiology
Animals ; Chick Embryo ; Humans ; Rats ; Angiogenesis Inhibitors/pharmacology ; Cell Movement ; Cell Proliferation ; Human Umbilical Vein Endothelial Cells/metabolism ; Neovascularization, Physiologic/drug effects ; Neovascularization, Physiologic/physiology ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphoinositide-3 Kinase Inhibitors ; Proto-Oncogene Proteins c-akt/metabolism
Czasopismo naukowe
Tytuł:
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC.
Autorzy:
Li JP; Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, Jiangsu, China.; Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China.; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.
Liu YJ; Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China.; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.
Zeng SH; Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China.; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.
Gao HJ; Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, Jiangsu, China.
Chen YG; Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China. .
Zou X; Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China. .; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China. .; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, 210023, China. .
Pokaż więcej
Źródło:
Cellular & molecular biology letters [Cell Mol Biol Lett] 2022 Sep 05; Vol. 27 (1), pp. 76. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Fibroblast Growth Factor 1*
Electron Transport Complex IV/*metabolism
Epithelial-Mesenchymal Transition/genetics ; Humans ; Hypoxia/genetics ; Neovascularization, Pathologic ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
FGF1 delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis.
Autorzy:
Lin Q; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA. Electronic address: .
Chen O; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
Wise JP Jr; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
Shi H; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Wintergerst KA; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Division of Endocrinology, Department of Pediatrics, University of Louisville, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA.
Cai L; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA.
Tan Y; Pediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA. Electronic address: .
Pokaż więcej
Źródło:
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2022 Aug 01; Vol. 1868 (8), pp. 166414. Date of Electronic Publication: 2022 Apr 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/metabolism
Fibroblast Growth Factor 1*/genetics
Fibroblast Growth Factor 1*/therapeutic use
Animals ; Apoptosis ; Disease Models, Animal ; Fibrosis ; Humans ; Inflammation/drug therapy ; Inflammation/metabolism ; Mice ; PPAR alpha/metabolism
Czasopismo naukowe
Tytuł:
Impact of Bmal1 Rescue and Time-Restricted Feeding on Liver and Muscle Proteomes During the Active Phase in Mice.
Autorzy:
Smith JG; Department of Medical and Life Sciences (MELIS), Pompeu Fabra University (UPF), Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain.
Molendijk J; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Melbourne, Victoria, Australia.
Blazev R; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Melbourne, Victoria, Australia.
Chen WH; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA; Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, San Antonio, Texas, USA.
Zhang Q; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Litwin C; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Zinna VM; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Welz PS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Hospital del Mar Research Institute Barcelona, Cancer Research Program, Barcelona Biomedical Research Park (PRBB), Barcelona, Spain.
Benitah SA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Greco CM; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Sassone-Corsi P; Department of Biological Chemistry, Center for Epigenetics and Metabolism, U1233 INSERM, University of California, Irvine, California, USA.
Muñoz-Cánoves P; Department of Medical and Life Sciences (MELIS), Pompeu Fabra University (UPF), Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain; Altos Labs, Inc, San Diego Institute of Science, San Diego, California, USA.
Parker BL; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Melbourne, Victoria, Australia. Electronic address: .
Koronowski KB; Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, San Antonio, Texas, USA; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA. Electronic address: .
Pokaż więcej
Źródło:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2023 Nov; Vol. 22 (11), pp. 100655. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
Circadian Clocks*/genetics
Circadian Rhythm*/genetics
Animals ; Mice ; ARNTL Transcription Factors/genetics ; ARNTL Transcription Factors/metabolism ; Chromatography, Liquid ; Fibroblast Growth Factor 1/metabolism ; Liver/metabolism ; Muscles/metabolism ; Proteome/metabolism ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł:
Fgf, Hh, and pax2a differentially regulate expression of pax5 and pou3f3b in vestibular and auditory maculae in the zebrafish otic vesicle.
Autorzy:
Tan AL; Biology Department, Texas A&M University, Texas, USA.
Christensen SE; Biology Department, Texas A&M University, Texas, USA.
Baker AK; Biology Department, Texas A&M University, Texas, USA.
Riley BB; Biology Department, Texas A&M University, Texas, USA.
Pokaż więcej
Źródło:
Developmental dynamics : an official publication of the American Association of Anatomists [Dev Dyn] 2023 Oct; Vol. 252 (10), pp. 1269-1279. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Ear, Inner*/metabolism
Zebrafish*/metabolism
Animals ; Mice ; Hearing ; PAX2 Transcription Factor/genetics ; PAX2 Transcription Factor/metabolism ; Zebrafish Proteins/genetics ; Zebrafish Proteins/metabolism ; Fibroblast Growth Factor 1 ; Hedgehog Proteins ; Fibroblast Growth Factors
Czasopismo naukowe
Tytuł:
Fibroblast growth factor 9 (FGF9)-mediated neurodegeneration: Implications for progressive multiple sclerosis?
Autorzy:
Thümmler K; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Wrzos C; Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Franz J; Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.; Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.; Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.; Göttingen Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.
McElroy D; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Cole JJ; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Hayden L; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Arseni D; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Schwarz F; Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Junker A; Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.; Department of Neuropathology, University Hospital Essen, Essen, Germany.
Edgar JM; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Kügler S; Institute for Neurology, University Medical Center Göttingen, Göttingen, Germany.; Center Nanoscale Microscopy and Physiology of the Brain (CNMPB), Göttingen, Germany.
Neef A; Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.; Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.; Göttingen Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.; Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.
Wolf F; Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.; Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.; Göttingen Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.; Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.; Cluster of Excellence Multiscale Bioimaging: From Molecular Machines to Network of Excitable Cells (MBExC), University of Goettingen, Göttingen, Germany.
Stadelmann C; Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.; Cluster of Excellence Multiscale Bioimaging: From Molecular Machines to Network of Excitable Cells (MBExC), University of Goettingen, Göttingen, Germany.
Linington C; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2023 Oct; Vol. 49 (5), pp. e12935.
Typ publikacji:
Journal Article
MeSH Terms:
Depressive Disorder, Major*
Multiple Sclerosis*
Animals ; Rats ; Fibroblast Growth Factor 1 ; Fibroblast Growth Factor 2 ; Fibroblast Growth Factor 9
Czasopismo naukowe
Tytuł:
Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway.
Autorzy:
Lu G; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Liu Q; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Gao T; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Li J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Zhang J; Department of Cardiology at the First Hospital of China Medical University, Shenyang 110016, China.
Chen O; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Cao C; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Mao M; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Xiao M; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Zhang X; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Wang J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Guo Y; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Tang Y; Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China.
Gu J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2022 Sep 27; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiotoxicity*/drug therapy
Fibroblast Growth Factor 1*/pharmacology
NF-E2-Related Factor 2*/metabolism
Resveratrol*/pharmacology
Sirtuin 1*/metabolism
Animals ; Apoptosis ; Doxorubicin/toxicity ; Mice ; Mice, Inbred C57BL ; Myocytes, Cardiac ; Oxidative Stress
Czasopismo naukowe
Tytuł:
Sustained inhibition of NPY/AgRP neuronal activity by FGF1.
Autorzy:
Hwang E; Department of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Scarlett JM; Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.; Department of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, Seattle, Washington, USA.
Baquero AF; Obesity Research, Novo Nordisk Research Center Seattle, Seattle, Washington, USA.
Bennett CM; Obesity Research, Novo Nordisk Research Center Seattle, Seattle, Washington, USA.
Dong Y; Department of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Chau D; Department of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Brown JM; Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.; University of Copenhagen, Novo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen, Denmark.
Mercer AJ; Obesity Research, Novo Nordisk Research Center Seattle, Seattle, Washington, USA.
Meek TH; Obesity Research, Novo Nordisk Research Center Seattle, Seattle, Washington, USA.; Discovery Technologies & Genomics, Novo Nordisk Research Centre Oxford, Oxford, United Kingdom.
Grove KL; Obesity Research, Novo Nordisk Research Center Seattle, Seattle, Washington, USA.
Phan BAN; Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Morton GJ; Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Williams KW; Department of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Schwartz MW; Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington, USA.
Pokaż więcej
Źródło:
JCI insight [JCI Insight] 2022 Sep 08; Vol. 7 (17). Date of Electronic Publication: 2022 Sep 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Fibroblast Growth Factor 1*/pharmacology
Agouti-Related Protein/pharmacology ; Animals ; Hypoglycemic Agents/pharmacology ; Neurons
Czasopismo naukowe
Tytuł:
Cardioprotective efficacy of Xin-shu-bao tablet in heart failure with reduced ejection fraction by modulating THBD/ARRB1/FGF1/STIM1 signaling.
Autorzy:
Zhang F; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Xu X; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Hou J; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Xiao H; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Guo F; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Li X; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: phd_.
Yang H; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China; China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Sep; Vol. 165, pp. 115119. Date of Electronic Publication: 2023 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure*/drug therapy
Heart Failure*/metabolism
Myocardial Infarction*/drug therapy
Animals ; Mice ; Stroke Volume ; Fibroblast Growth Factor 1/metabolism ; Arrestin/metabolism ; Stromal Interaction Molecule 1 ; Thrombomodulin
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies